Jaffetilchin Investment Partners LLC Acquires New Holdings in IQVIA Holdings Inc. (NYSE:IQV)

Jaffetilchin Investment Partners LLC purchased a new stake in shares of IQVIA Holdings Inc. (NYSE:IQV - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 7,598 shares of the medical research company's stock, valued at approximately $1,493,000.

Several other hedge funds have also made changes to their positions in the stock. Pine Valley Investments Ltd Liability Co increased its stake in IQVIA by 0.5% during the 3rd quarter. Pine Valley Investments Ltd Liability Co now owns 9,481 shares of the medical research company's stock worth $2,247,000 after purchasing an additional 50 shares in the last quarter. Howard Capital Management Inc. raised its stake in IQVIA by 4.9% in the fourth quarter. Howard Capital Management Inc. now owns 1,147 shares of the medical research company's stock valued at $225,000 after purchasing an additional 54 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its stake in IQVIA by 1.0% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 5,434 shares of the medical research company's stock worth $1,068,000 after acquiring an additional 56 shares in the last quarter. Cypress Wealth Services LLC boosted its position in IQVIA by 4.8% during the 4th quarter. Cypress Wealth Services LLC now owns 1,243 shares of the medical research company's stock worth $244,000 after buying an additional 57 shares during the period. Finally, Harbor Investment Advisory LLC raised its holdings in IQVIA by 4.7% during the 4th quarter. Harbor Investment Advisory LLC now owns 1,286 shares of the medical research company's stock worth $253,000 after purchasing an additional 58 shares during the last quarter. Institutional investors own 89.62% of the company's stock.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on IQV. Mizuho cut their price objective on shares of IQVIA from $242.00 to $210.00 and set an "outperform" rating on the stock in a report on Wednesday, April 9th. Truist Financial dropped their price objective on shares of IQVIA from $263.00 to $216.00 and set a "buy" rating for the company in a report on Thursday, April 10th. Royal Bank of Canada restated an "outperform" rating and set a $270.00 price target on shares of IQVIA in a research report on Monday, February 10th. Citigroup decreased their price objective on shares of IQVIA from $225.00 to $210.00 and set a "neutral" rating for the company in a report on Tuesday, March 4th. Finally, StockNews.com downgraded shares of IQVIA from a "buy" rating to a "hold" rating in a research note on Wednesday, March 12th. Six research analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $241.50.

IQVIA Stock Performance

NYSE:IQV traded down $3.66 during trading hours on Thursday, hitting $144.78. 1,412,070 shares of the company traded hands, compared to its average volume of 1,393,191. The firm has a 50-day moving average of $178.83 and a 200 day moving average of $198.11. The company has a current ratio of 0.84, a quick ratio of 0.84 and a debt-to-equity ratio of 2.12. IQVIA Holdings Inc. has a twelve month low of $135.97 and a twelve month high of $252.88. The stock has a market capitalization of $25.53 billion, a price-to-earnings ratio of 19.35, a P/E/G ratio of 1.99 and a beta of 1.46.

IQVIA (NYSE:IQV - Get Free Report) last released its earnings results on Thursday, February 6th. The medical research company reported $2.90 earnings per share for the quarter, missing analysts' consensus estimates of $3.11 by ($0.21). IQVIA had a return on equity of 28.81% and a net margin of 8.91%. On average, analysts forecast that IQVIA Holdings Inc. will post 10.84 EPS for the current year.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.